Dental amalgam controversy cause harm in patients." Also, in the FDA final regulation on dental amalgam in 2009, the FDA recommended the product labeling of dental amalgam. The suggested labeling included: a warning against the use of dental amalgam in patients with mercury allergy, a warning that dental professionals use appropriate ventilation when handling dental amalgam, and a statement discussion of scientific evidence on dental amalgam's risks and benefits in order to make informed decisions amongst patient and professional dentists. The use of mercury in dental fillings is considered safe and effective in all countries practicing modern dentistry (see below). There are currently
Dental amalgam controversy they contain Bis-phenol A (BPA) a chemical known to cause reproductive toxicity at high doses. In Canada, amalgam use is considered safe and effective. A 2005 position statement from the Canadian Dental Association (CDA) states that "current scientific evidence on the use of dental amalgam supports that amalgam is an effective and safe filling material that provides a long-lasting solution for a broad range of clinical situations. The CDA has established its position based on the current consensus of scientific and clinical experts and on recent extensive reviews of strong evidence by major North American and international organizations, which have